Publicaciones en colaboración con investigadores/as de Montreal Heart Institute (5)

2023

  1. New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022

    European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 9, Núm. 4, pp. 353-370

  2. Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease?

    European heart journal. Cardiovascular pharmacotherapy, Vol. 9, Núm. 6, pp. 570-582

2004

  1. The Kv4.2 N-terminal restores fast inactivation and confers KChIP2 modulatory effects on N-terminal-deleted Kv1.4 channels

    Pflugers Archiv European Journal of Physiology, Vol. 449, Núm. 3, pp. 235-247

2003

  1. Effects of flecainide and quinidine on Kv4.2 currents: Voltage dependence and role of S6 valines

    British Journal of Pharmacology, Vol. 138, Núm. 8, pp. 1475-1484

2002

  1. A comparison of currents carried by HERG, with and without coexpression of MiRP1, and the native rapid delayed rectifier current. Is MiRP1 the missing link?

    Journal of Physiology, Vol. 540, Núm. 1, pp. 15-27